TITLE

Inhaled Corticosteroids: Why Do Physicians and Patients Fail to Comply With Guidelines for Managing Asthma?

AUTHOR(S)
Reed, Charles E.
PUB. DATE
April 2004
SOURCE
Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p453
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Points out that failure of physicians to prescribe inhaled corticosteroids for patients with persistent, even mild persistent, asthma has a major adverse impact on the quality of life and healthcare costs. Reasons why physicians do not prescribed inhaled corticosteroids; Disagreement of physicians with the recommendation.
ACCESSION #
12736154

 

Related Articles

  • Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind Placebo-Controlled Trial. Kemp, James P.; Osur, Scott; Shrewsbury, Stephen B.; Herje, Nancy E.; Duke, Susan P.; Harding, Stuart M.; Faulkner, Kennethf; Crim, Courtney C. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p458 

    • Objective: To evaluate the effects of treatment with fluticasone propionate vs placebo on bone, hypothalamicpituitary-adrenal (HPA) axis function, and the eyes in patients with asthma. • Patients and Methods: This randomized, double-blind, placebo-controlled study of 160 patients...

  • Step One for Asthma Treatment: β-Agonists or Inhaled Corticosteroids? Redington, A.E. // Drugs;Jul2001, Vol. 61 Issue 9, p1231 

    Inhaled corticosteroids have proven effectiveness in chronic persistent asthma and are now recommended as first-line therapy in this condition. In contrast, long term preventative therapy is not currently considered necessary for patients with disease that is only mild and episodic. Recently,...

  • Asthma drug works as rescue therapy.  // GP: General Practitioner;2/18/2011, p8 

    The article offers information ont he research conducted related to asthma drug working as rescue therapy. It states that using inhaled corticosteroids as rescue therapy for asthma instead of as daily treatment could reduce related side-effects. It mentions that the researchers found that rescue...

  • Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Is There a Clinical Benefit? Man, S. F. Paul; Sin, Don D. // Drugs;2005, Vol. 65 Issue 5, p579 

    Chronic obstructive pulmonary disease (COPD) is a serious illness that affects over 5% of the adult population. It is one of the few conditions for which the mortality and morbidity are still increasing. Experts expect COPD to become the third leading cause of death and the fifth leading cause...

  • Análise da Revisão Cochrane: Uso de Corticoterapia Sistémica nas Exacerbações Agudas da Doença Pulmonar Obstrutiva Crónica. Cochrane Database Syst Rev. 2014, 9:CD001288. AZEVEDO, Pedro; COSTA, João; VAZ-CARNEIRO, António // Acta Medica Portuguesa;set/out2014, Vol. 27 Issue 5, p537 

    Acute exacerbations of chronic obstructive pulmonary disease are a major cause of hospital admissions and mortality, contributing to the decline in lung function, exercise capacity and quality of life. Infections are the major cause of exacerbations and treatment includes antibiotics,...

  • Chronic Obstructive Pulmonary Disease: Emerging Trends in Pharmacotherapy. Restrepo, Ruben D.; Hanania, Nicola A. // Current Medical Literature: Respiratory Medicine;2009, Vol. 23 Issue 2, p29 

    The article reviews emerging therapies for the treatment of stable chronic obstructive pulmonary disease (COPD). The two categories of inhaled agents for the management of stable COPD are bronchodilators and corticosteroids. It explains in detail the use of novel biological targets like novel...

  • Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD?  // Journal of Family Practice;Dec2003, Vol. 52 Issue 12, p979 

    Systemic corticosteroids improve measures of dyspnea in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). The optimal dose of systemic corticosteroids to achieve these benefits is uncertain. An international consensus panel recommended 30 to 40 mg of oral...

  • Encapsulated trabeculectomy blebs resolve in study. Charters, Lynda // Ophthalmology Times;12/1/2005, Vol. 30 Issue 23, p14 

    This article presents information on a study which is related to encapsulated trabeculectomy blebs. In the study, the presence of an encapsulated bleb was defined as documentation of a Tenon's capsule cyst or an enalone. Filtering bleb encapsulation after trabeculectomy responds well to tapering...

  • Using exhaled NO concentrations to adjust inhaled corticosteroid dose maintained asthma control and reduced the dose. Smith, A. D.; Cowan, J. O.; Brassett, K. P.; Taylor, R. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics